Российский национальный исследовательский медицинский университет им. Н.И. Пирогова Минздрава России, Москва, Россия
Российский национальный исследовательский медицинский университет им. Н.И. Пирогова Минздрава России, Москва, Россия
INTRODUCTION. The article reflects long-term and distant consequences of antitumor therapy, from three to six months from the beginning of treatment, in patients with breast cancer. Analysis of the identified effects allowed to determine the structure of the rehabilitation diagnosis based on the International Classification of Functioning. AIM. To designate the main International Classification of Functioning codes for breast cancer patients corresponding to the third stage of rehabilitation, to evaluate the effectiveness of rehabilitation measures at this stage of rehabilitation in breast cancer patients who received different methods of treatment for this disease. MATERIAL AND METODS. The study was conducted on the basis Federal Research and Clinical Center of Radiology and Oncology of the Federal Medical and Biological Agency of Russia for the period October-January 2021-2022, including the data analysis of 40 patients (all women) with breast cancer stages I-IV, being at the third stage of rehabilitation 3-6 months after the complex antitumor treatment with the persistence of adverse events due to the therapy, the mean age of patients is 58 .6 ± 1.2 years. RESULTS AND DISCUSSION. The need for rehabilitation measures in patients with breast cancer persisted and increased after the end of antitumor treatment. A brief set of International Classification of Functioning was formed on the basis of complaints and evaluation of patients admitted to the third stage of medical rehabilitation from the standpoint of a biopsychosocial approach. Rehabilitation diagnosis distinctive features were identified and, accordingly, the rehabilitation program was developed at the third stage of medical rehabilitation of patients with breast cancer. CONCLUSION. The results of the study confirm the long-term effects of antitumor treatment, which suggests the need for rehabilitation measures to prevent the development and progression of complications and to improve the quality of life of breast cancer patients.
quality of life, International Classification of Functioning, data analysis, breast cancer, patients, antitumor therapy, rehabilitation, long term effects
1. Sych G.V., Kosolapov V.P., Choporov O.N., Dzhavahadze R.E. Mediko-social'nye harakteristiki zhenschin s onkologicheskimi zabolevaniyami. Problemy social'noy gigieny, organizacii zdravoohraneniya i istorii mediciny. 2018; 26(5): 297-301. https://doi.org/10.32687/0869-866X-2018-26-5-297-301
2. Fahad Ullah M. Breast Cancer: Current Perspectives on the Disease Status. Advances in Experimental Medicine and Biology. 2019; (1152): 51-64. https://doi.org/10.1007/978-3-030-20301-6_4
3. Kaprin A.D., Starinskiy V.V., Shahzadova A.O. Zlokachestvennye novoobrazovaniya v Rossii v 2020 godu (zabolevaemost' i smertnost'). MNIOI im. P.A. Gercena − filial FGBU «NMIC radiologii» Minzdrava Rossii. 2021: 252 s.
4. Kaprin A.D., Starinskiy V.V., Shahzadova A.O. Sostoyanie onkologicheskoy pomoschi naseleniyu Rossii v 2019 godu. MNIOI im. P.A. Gercena − filial FGBU «NMIC radiologii» Minzdrava Rossii. 2020: 239 s.
5. Puzin S.N., Shurgaya M.A., Achkasov E.E., Memetov S.S., Pogosyan G.S., Idrisova L.S. Mediko-social'nye aspekty povtornoy invalidizacii vzroslogo naseleniya vsledstvie zlokachestvennyh novoobrazovaniy v Rossiyskoy Federacii. Problemy social'noy gigieny, organizacii zdravoohraneniya i istorii mediciny. 2019; 27(1): 18-22. https://doi.org/10.32687/0869-866X-2019-27-1-18-22
6. Volchenko A.A. Pak D.A. Rekonstruktivno-plasticheskie operacii pri kompleksnom lechenii bol'nyh rakom molochnoy zhelezy. Rossiyskiy onkologicheskiy zhurnal. 2012; (2): 46-49.
7. Lovelace D.L., McDaniel L.R., Golden D. Long-Term Effects of Breast Cancer Surgery, Treatment, and Survivor Care. Journal of Midwifery & Women’s Health. 2019; 64(6): 713-724. https://doi.org/10.1111/jmwh.13012
8. Acebedo J.C., Haas B.K., Hermanns M. Breast Cancer-Related Lymphedema in Hispanic Women: A Phenomenological Study. Journal of Transcultural Nursing. 2021; 32(1): 41-49. https://doi.org/10.1177/1043659619891236
9. Ruiz-Casado A., Álvarez-Bustos A., de Pedro C.G., Méndez-Otero M., Romero-Elías M. Cancer-related Fatigue in Breast Cancer Survivors: A Review. Clinical Breast Cancer. 2021; 21(1): 10-25. https://doi.org/10.1016/j.clbc.2020.07.011
10. Maass S.W., Roorda C., Berendsen A.J., Verhaak P.F., de Bock G.H. The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment: a systematic review. Maturitas. 2015; 82(1): 100-108. https://doi.org/10.1016/j.maturitas.2015.04.010
11. Fangel L.M., Panobianco M.S., Kebbe L.M., de Almeida A.M., de Oliveira Gozzo T. Qualify of life and daily activities performance after breast cancer treatment. Acta Paulista de Enfermagem. 2013; 26(1): 93-100. https://doi.org/10.1590/S0103-21002013000100015
12. Keesing S., Rosenwax L., McNamara B. The implications of women’s activity limitations and role disruptions during breast cancer survivorship. Women’s Health. 2018; (14): 1745505718756381. https://doi.org/10.1177/1745505718756381
13. Dunne M., Keenan K. CE: late and long-term sequelae of breast cancer treatment. American Journal of Nursing. 2016; 116(6): 36-45. https://doi.org/10.1097/01.NAJ.0000484223.07306.45
14. Kothari A.S., Fentiman I.S. Breast cancer in young women. International Journal of Clinical Practice. 2002; 56(3): 184-187.
15. Gonciar D., Mocan L., Zlibut A., Mocan T., Agoston-Coldea L. Cardiotoxicity in HER2-positive breast cancer patients. Heart Failure Reviews. 2021; 26(4): 919-935. https://doi.org/10.1007/s10741-020-10072-8
16. Udalov Yu.D., Belova L.A., Mashin V.V., Danilova L.A., Kuvayskaya A.A. Porazhenie vegetativnoy nervnoy sistemy u bol'nyh rakom molochnoy zhelezy. Ul'yanovskiy mediko-biologicheskiy zhurnal. 2021; (4): 73-88. https://doi.org/10.34014/2227-1848-2021-4-73-88
17. González-Santos Á., Postigo-Martin P., Gallart-Aragón T., Esteban-Cornejo I., Lopez-Garzon M., Galiano-Castillo N., Arroyo-Morales M., Illescas-Mon- tes R., Artacho-Cordón F., Martín-Martín L., Forneiro-Pérez R., Lozano-Lozano M., Fernández-Lao C., Ruiz-Vozmediano J., Sánchez-Salgado C., Can- tarero-Villanueva I. Neurotoxicity prevention with a multimodal program (ATENTO) prior to cancer treatment versus throughout cancer treatment in women newly diagnosed for breast cancer: Protocol for a randomized clinical trial. Research in Nursing, Health. 2021; 44(4): 598-607. https://doi.org/10.1002/nur.22136
18. Fang C.Y., Lou D.Y., Zhou L.Q., Wang, J.C., Yang B., He Q.J., Wang J.J., Weng Q.J. Natural products: potential treatments for cisplatin-induced nephrotoxicity. Acta Pharmacologica Sinica. 2021; (42): 1951-1969. https://doi.org/10.1038/s41401-021-00620-9
19. Klyuge V.A., Semiglazova T.Yu., Krivorot'ko P.V., Mel'nikova E.V., Kasparov B.S., Kondrat'eva K.O., Semenyuk M.V., Tynkasova M.A., Kovlen D.V., Adhamov B.M., Zernov K.Yu., Pesockiy R.S., Ryazankina A.A., Semiletova Yu.V., Nazarova S.G., Semiglazov V.V., Semiglazov V.F., Belyaev A.M. Opyt primeneniya mezhdunarodnoy klassifikacii funkcionirovaniya (MKF) u bol'nyh operabel'nym rakom molochnoy zhelezy dlya ocenki potrebnosti v reabilitacii. Vestnik vosstanovitel'noy mediciny. 2021; 20(1): 70-83. https://doi.org/10.38025/2078-1962-2021-20-1-70-83
20. Schmidt M.E., Schere S., Wiskemann J., Steindorf K. Return to work after breast cancer: The role of treatment-related side effects and potential impact on quality of life. European Journal of Cancer Care. 2019; 28(4): e13051. https://doi.org/10.1111/ecc.13051
21. Seretny M, Currie G.L., Sena E.S., Ramnarine S., Grant R., MacLeod M.R., Colvin L.A., Fallon M. Incidence, prevalence, and predictors of chemotherapy induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014; (155): 2461-2470. https://doi.org/10.1016/j.pain.2014.09.020
22. Wolf S.L., Barton D.L., Qin R., Wos E.J., Sloan J.A., Liu H., Aaronson N.K., Satele D.V., Mattar B.I., Green N.B., Loprinzi C.L. The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA. Supportive Care in Cancer. 2012; 20(3): 625-632. https://doi.org/10.1007/s00520-011-1141-9
23. Mols F., Beijers T., Vreugdenhil G., van de Poll-Franse L. Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Supportive Care in Cancer. 2014; (22): 2261-2269. https://doi.org/10.1007/s00520-014-2255-7
24. Mols F., Beijers T., Lemmens V., van den Hurk CJ., Vreugdenhil G., van de Poll-Franse L.V. Chemotherapy-induced neuropathy and its association with quality of life among 2 to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. Journal of Clinical Oncology. 2013; 31(21): 2699-2707. https://doi.org/10.1200/JCO.2013.49.1514
25. Marmiroli P., Scuteri A., Cornblath D.R., Cavaletti G. Pain in chemotherapy-induced peripheral neurotoxicity. JPNS. 2017; 22(3): 156-161. https://doi.org/10.1111/jns.12226
26. Gewandter J.S., Freeman R., Kitt R.A., Cavaletti G., Gauthier L.R., McDermott M.P., Mohile N.A., Mohlie S.G., Smith A.G., Tejani M.A., Turk D.C., Dworkin R.H. Chemotherapy-induced peripheral neuropathy clinical trials: Review and recommendations. Neurology. 2017; (89): 859-869. https://doi.org/10.1212/WNL.0000000000004272
27. Flatters S., Dougherty P.M., Colvin L.A. Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review. British Journal of Anaesthesia. 2017; (119): 737-749. https://doi.org/10.1093/bja/aex229
28. Lakoski S.G., Jone L.W., Krone R.J., Stein P.K., Scott J.M. Autonomic dysfunction in early breast cancer: Incidence, clinical importance, and underlying mechanisms. American Heart Journal. 2015; 170(2): 231-41. https://doi.org/10.1016/j.ahj.2015.05.014
29. Jerusalem G., Lancellotti P., Kim S.B. HER2+ breast cancer treatment and cardiotoxicity: monitoring and management. Breast Cancer Research and Treatment. 2019; 177(2): 237-250. https://doi.org/10.1007/s10549-019-05303-y
30. Noor B., Akhavan S., Leuchter M., Yang E.H., Ajijola O.A. Quantitative assessment of cardiovascular autonomic impairment in cancer survivors: a sin- gle center case series. Cardio-Oncology. 2020; (6): 11. https://doi.org/10.1186/s40959-020-00065-9
31. Ivanova G.E. Medicinskaya reabilitaciya v Rossii. Perspektivy razvitiya. Consilium Medicum. 2016; 18(2.1): 9-13.
32. Amatya B., Khan F., Galea M.P. Optimizing post-acute care in breast cancer survivors: a rehabilitation perspective. Journal of Multidisciplinary Healthcare. 2017; (10): 347-357. https://doi.org/10.2147/JMDH.S117362
